Short-term therapy with antibiotics for bacterial infections in the ENT and pulmonary field;Kurzzeittherapie bei bakteriellen infektionen im HNO- und atemwegsbereich mit oralen antibiotika

Chemotherapie Journal

Volumn 10, Issue 4, 2001, Pages 128-132

  Adam, D ^a   Troster K ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAMASE INHIBITOR; CEFDINIR; CEFIXIME; CEFPODOXIME; CEFPROZIL; CEFUROXIME AXETIL; CEPHALOSPORIN DERIVATIVE; CLARITHROMYCIN; MACROLIDE; MOXIFLOXACIN; PENICILLIN DERIVATIVE; QUINOLONE DERIVATIVE; ROXITHROMYCIN; SPARFLOXACIN;

ANTIBIOTIC THERAPY; BACTERIAL INFECTION; CHRONIC BRONCHITIS; DISEASE EXACERBATION; FORCED EXPIRATORY VOLUME; HUMAN; LUNG INFECTION; OTITIS MEDIA; OTORHINOLARYNGOLOGY; PHARYNGITIS; REVIEW; TONSILLITIS;

EID: 0034852432     PISSN: 09406735     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Trial of three-day and ten-day courses of amoxycillin in otitis media
2. Antimicrobial resistance is a major threat to public health
3. Low dosage and long treatment duration of β-lactam. Risk factors for carriage of penicillinresistant Streptococcus pneumoniae
4. Shortened course of antibiotic therapy for acute otitis media, sinusitis and tonsillopharyngitis
5. Ascertaining how much compliance is enough with outpatient antibiotic regimens
6. Failure of children to receive penicillin by mouth
7. Prescription and consommation des antibiotiques en ambulatoire
8. Antibiotika-therapie der akuten otitis media
9. Antibiotics for otitis media: Restraint, not routine
10. Single dose amoxicillin treatment of acute otitis media
11. Two versus seven days penicillin treatment for acute otitis media
12. Penicillin treatment of acute otitis media in children
13. Single-dose intramuscular ceftriaxone for acute otitis media in children
14. N.N. new antimicrobial agents approved by the U.S. Food and Drug Administration in 1997 and new indications for previously approved agents
15. Five-day versus ten-day treatment of acute otitis media with cefprozil
16. Treatment of acute otitis media with a shortened course of antibiotics
17. Short-course antimicrobial treatment for acute otitis media
18. A multicenter, randomized, double-blind trial of 5 versus 10 days of antibiotic therapy for acute otitis media in young children
19. Medical therapy of otitis media: Use, abuse, efficacy and morbidity
20. Acute exacerbation of chronic bronchitis: An international comparison
21. Acute bacterial exacerbations of bronchitis and asthma
22. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease
23. Rationale therapie bakterieller atemwegsinfektionen
24. Efficacy and tolerability of 5-vs 10-day cefixime therapy in acute exazerbations of chronic bronchitis
25. Effectiveness of short-course therapy (5 days) with cefuroxime axetil in treatment of secondary bacterial infections of acute bronchitis
26. Short-course cefuroxime axetil therapy in the treatment of acute exazerbations of chronic bronchitis
27. Roxithromycin 5 days versus azithromycin 3 days in AECB and acute bronchitis
28. Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis
29. Randomized, double-blind study of short-course (5 day) grepafloxacin versus 10 day clarithromycin in patients with acute bacterial exacerbations of chronic bronchitis
30. Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitis
31. Controversies in the treatment of streptococcal pharyngitis
32. Streptococcal pharyngitis: A Belgian perspective
33. Statements of American Heart Association Council on rheumatic fever and congenital heart disease
34. Meta-analysis in the evaluation of treatment for streptococcal pharyngitis: A review
35. An analysis of the cost-effectiveness of pharyngitis management and acute rheumatic fever prevention
36. Cefixim und andere oralcephalosporine zur behandlung der a-streptokokken-tonsillitis
37. Rheumatic fever
38. Streptococcal pharyngitis in the general population. II. The attack rate of rheumatic fever and acute glomerulonephritis in patients not treated with penicillin
39. Are antibiotics appropriate for sore throats?
40. Welche inzidenz hat das rheumatische fieber in Deutschland?
41. Evaluation of penicillins, cephalosporins and macrolides for therapy of streptococcal pharyngitis
42. Multicenter comparative trial of cefixime and phenoxymethylpenicillin for group A beta-hemolytic streptococcal tonsillitis
43. 5-Day cefixime therapy for bacterial pharyngitis and/or tonsillitis: Comparison with 10-day penicillin V therapy
44. Five day treatment of pharyngotonsillitis with cefpodoxime proxetil
45. Five-day cefdinir treatment for streptococcal pharyngitis
46. Comparative efficacy and safety of four-day cefuroxime axetil and ten-day penicillin treatment of group A beta-hemolytic streptococcal pharyngitis in children
47. 6-Day amoxicillin versus 10-day penicillin V for group A β-hemolytic streptococcal acute tonsillitis in adults: A French multicentre, openlabel, randomized study
48. Comparison of short-course (5 day) cefuroxime axetil with a standard 10 day oral penicillin V regimen in the treatment of tonsillopharyngitis
49. Shortcourse antibiotic treatment of 4782 cultureproven cases of Group A streptococcal tonsillopharyngitis and incidence of poststreptococcal sequelae
50. Group A beta-hemolytic streptococcal infections
51. Azithromycin and amoxicillin in the treatment of acute maxillary sinusitis
52. Efficacité et tolérance de céfixime en traitement de 4 jours ou de 10 jours versus 10 jours d'amoxicilline-acide clavulanique dans les sinusites aiguës de l'adulte
53. Sparfloxacin versus cefuroxime axetil in the treatment of acute purulent sinusitis
54. Deutsche gesellschaft für pädiatrische infektiologie